Geostatistical modelling enables efficient safety assessment for mass drug administration with ivermectin in Loa loa endemic areas through a combined antibody and LoaScope testing strategy for elimination of onchocerciasis

PLOS Neglected Tropical Diseases 16(2):e0010189 (2022)

Journal article

Authors

Olatunji Johnson

Emanuele Giorgi

Claudio Fronterrè

Benjamin Amoah

et al.

Published

February 9, 2022

Doi

10.1371/journal.pntd.0010189

Links: Publisher (DOI) · Open Access (PMC)

Summary. Two-stage strategy (antibody screening → targeted LoaScope) with a multivariate geostatistical model to classify areas as safe/unsafe for ivermectin MDA.